Clinical Trials Sponsored by Roberta Ballard

Total 2368 results

AHS Cancer Control Alberta

Not yet recruiting

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)

Arthritis | Arthralgia
AHS Cancer Control Alberta

Not yet recruiting

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) (IMPACT 1)

Diarrhea | Advanced Melanoma | Immune-related Adverse Event | Advanced Rectal Carcinoma

Canada
AHS Cancer Control Alberta

Recruiting

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Pancreatic Cancer | Cholangiocarcinoma | Biliary Tract Cancer | Hepatocellular Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

Breast Cancer Triple Negative

Canada
Alberta Health Services, Calgary

Recruiting

Neuromodulation Parameter Efficacy

Chronic Pain

Canada
AHS Cancer Control Alberta

Recruiting

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (ACT-FAST)

Brain Metastases, Adult

Canada
AHS Cancer Control Alberta

Recruiting

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Cancer

Canada
University of Alberta
Octapharma

Recruiting

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

Primary Immune Deficiency Disorder | Secondary Immune Deficiency

Canada
AHS Cancer Control Alberta

Active, not recruiting

A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (PRESTO)

Estrogen Receptor Positive Breast Cancer

Canada
University of Alberta
Pfizer

Completed

A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment

Overactive Bladder | Mild Cognitive Impairment

Canada
AHS Cancer Control Alberta

Terminated

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Renal Cell Carcinoma | Neuroendocrine Tumours

Canada
AHS Cancer Control Alberta

Completed

Breast Cancer and Exercise Trial in Alberta (BETA)

Breast Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Uveal Melanoma

Canada
AHS Cancer Control Alberta

Unknown

A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Prostate Cancer

Canada
University of Alberta
GlaxoSmithKline

Terminated

Asthma/Steroid Withdrawal Study

Asthma

Canada
AHS Cancer Control Alberta

Completed

Study of Tomotherapy in Patients With Benign Brain Tumour

Brain Neoplasms

Canada
University of Alberta
Bayer

Completed

Rivaroxaban Acute Stroke Safety Study (RASS)

Transient Ischemic Attack | Acute Ischemic Stroke

Canada
AHS Cancer Control Alberta

Completed

Tomotherapy Treatment for Mesothelioma

Mesothelioma

Canada
AHS Cancer Control Alberta

Withdrawn

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

Recurrent Glioblastoma

Canada
AHS Cancer Control Alberta

Terminated

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Terminated

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Breast Cancer

Canada
AHS Cancer Control Alberta

Completed

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Healthy

Canada
AHS Cancer Control Alberta

Terminated

Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy

Cardiac Toxicity | Genetic Markers | Breast and Skin Motion

Canada
AHS Cancer Control Alberta

Withdrawn

TORI 104 Pre-Surgical Dasatinib

Breast Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL

Lymphoma

Canada
AHS Cancer Control Alberta

Unknown

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Lung Neoplasm | Cell Hypoxia

Canada
AHS Cancer Control Alberta

Unknown

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Colorectal Cancer | Colorectal Carcinoma | Neoplasms, Colorectal

Canada
University of Alberta
Novartis

Completed

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Hepatitis C Virus

Canada
University of Alberta
Cross Cancer Institute; Northern Alberta Urology Centre

Recruiting

Bladder Cancer and exeRcise Training During intraVesical thErapy (BRAVE)

Bladder Cancer

Canada
Alberta Health services
Calgary Health Region

Completed

Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

PET/MRI in Rectal Cancer

Rectal Cancer
AHS Cancer Control Alberta

Recruiting

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Colorectal Cancer | Liver Metastasis Colon Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma (BIOSELECT)

Mycosis Fungoides

Canada
AHS Cancer Control Alberta

Recruiting

Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

High Heated Humidity in Stem Cell Transplant

Autologous Stem Cell Transplant

Canada
AHS Cancer Control Alberta

Not yet recruiting

Steroid Sparing in Immune Related Hepatitis (irH)

Hepatitis Immune
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Brain Metastases

Canada
Alberta Health Services, Calgary

Recruiting

Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis

Septic Shock

Canada
AHS Cancer Control Alberta

Recruiting

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (ATG2017)

Relapse | Graft-versus-host-disease

Canada
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
AHS Cancer Control Alberta

Terminated

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
AHS Cancer Control Alberta

Completed

iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Carcinoma

Canada
AHS Cancer Control Alberta

Terminated

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Bone Scan

Canada
University of Alberta
Pfizer

Active, not recruiting

Management of LUTS by Community Pharmacists

Lower Urinary Tract Symptoms

Canada
University of Alberta
Mitacs

Completed

Intraoral Ultrasound Imaging of Tooth-periodontium Complex

Periodontitis | Alveolar Bone Loss

Canada
AHS Cancer Control Alberta

Terminated

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (PREMIUM)

Prostatic Neoplasm

Canada

3

Subscribe